Chronic inflammatory effects of interleukin-1 on the blood-retina barrier.
The chronic effects of human recombinant IL-1 (hrIL-1) on the specialized vasculature of the central nervous system (CNS) and on the CNS itself have been examined over a 35-day period in the rabbit retina. A single intraocular injection of physiological levels of hrIL-1 (300 units) induced a biphasic inflammatory reaction with well-defined acute and chronic phases in the challenged eye. Quantitative histopathological examination of the vascularized portion of the retina in the IL-1-challenged eye documented a persistent mononuclear (MN) cell response that peaked 7-14 days post-challenge. Included in the MN cell count were perivascular plasma cells. Elevated protein levels in the vitreous persisted throughout the time points studied and alterations in vascular permeability of the epiretinal vessels were demonstrated by tracer leakage at 2 weeks post-challenge. The results show that exposure of the CNS-vasculature to IL-1 induces long-lasting inflammatory changes typical of a chronic inflammatory reaction.
Martiney
J A
JA
Department of Pathology, Albert Einstein College of Medicine, New York, NY.
Berman
J W
JW
Brosnan
C F
CF
D000818:Animals; D001813:Blood-Retinal Barrier / Q000187:drug effects*; D002908:Chronic Disease; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D007375:Interleukin-1 / Q000494:pharmacology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects; D011817:Rabbits; D011994:Recombinant Proteins / Q000494:pharmacology; D012160:Retina / Q000187:drug effects* / Q000473:pathology; D012173:Retinitis / Q000139:chemically induced* / Q000473:pathology
D007375:Interleukin-1; D011994:Recombinant Proteins